Patents/Assignees

Research Institute, Inc.

2 patents in portfolio

US12599621utility2026
Enhancing Anti-tumor Response in Melanoma Cells with Defective Sting Signaling
0 cites
US12584919utility2026
Enhancing Anti-tumor Response in Melanoma Cells with Defective Sting Signaling
0 cites